CL2019002741A1 - Bacterias de ácido láctico, métodos y usos de las mismos. - Google Patents

Bacterias de ácido láctico, métodos y usos de las mismos.

Info

Publication number
CL2019002741A1
CL2019002741A1 CL2019002741A CL2019002741A CL2019002741A1 CL 2019002741 A1 CL2019002741 A1 CL 2019002741A1 CL 2019002741 A CL2019002741 A CL 2019002741A CL 2019002741 A CL2019002741 A CL 2019002741A CL 2019002741 A1 CL2019002741 A1 CL 2019002741A1
Authority
CL
Chile
Prior art keywords
lactic acid
acid bacteria
methods
ethanolamine
bacteria
Prior art date
Application number
CL2019002741A
Other languages
English (en)
Inventor
Stefan Roos
Original Assignee
Biogaia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogaia Ab filed Critical Biogaia Ab
Publication of CL2019002741A1 publication Critical patent/CL2019002741A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/42—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y105/00—Oxidoreductases acting on the CH-NH group of donors (1.5)
    • C12Y105/01—Oxidoreductases acting on the CH-NH group of donors (1.5) with NAD+ or NADP+ as acceptor (1.5.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/03—Phosphoric monoester hydrolases (3.1.3)
    • C12Y301/03048—Protein-tyrosine-phosphatase (3.1.3.48)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y403/00—Carbon-nitrogen lyases (4.3)
    • C12Y403/01—Ammonia-lyases (4.3.1)
    • C12Y403/01007—Ethanolamine ammonia-lyase (4.3.1.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A NUEVAS CEPAS DE BACTERIAS DE ÁCIDO LÁCTICO, MÁS ESPECÍFICAMENTE, NUEVAS CEPAS DE LACTOBACILLUS REUTERI, CAPACES DE UTILIZAR ETANOLAMINA. ESTA CARACTERÍSTICA HACE POSIBLE QUE LAS BACTERIAS COMPITAN POR EL MISMO SUSTRATO QUE LOS PATÓGENOS QUE UTILIZAN ETANOLAMINA, PRESENTANDO ASÍ UN MEDIO EFICAZ PARA COMBATIR LAS INFECCIONES RESULTANTES DE TALES BACTERIAS PATÓGENAS. TAMBIÉN SE PROPORCIONA UN MÉTODO PARA SELECCIONAR BACTERIAS ADICIONALES DE ÁCIDO LÁCTICO QUE UTILIZAN ETANOLAMINA, ASÍ COMO OTROS MÉTODOS Y USOS QUE IMPLICAN DICHAS CEPAS NOVEDOSAS Y OTRAS BACTERIAS DE ÁCIDO LÁCTICO QUE UTILIZAN ETANOLAMINA.
CL2019002741A 2017-03-27 2019-09-26 Bacterias de ácido láctico, métodos y usos de las mismos. CL2019002741A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE1750363 2017-03-27

Publications (1)

Publication Number Publication Date
CL2019002741A1 true CL2019002741A1 (es) 2020-02-21

Family

ID=61899234

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2019002741A CL2019002741A1 (es) 2017-03-27 2019-09-26 Bacterias de ácido láctico, métodos y usos de las mismos.

Country Status (18)

Country Link
US (3) US11285181B2 (es)
EP (1) EP3601620A1 (es)
JP (1) JP7097382B2 (es)
KR (1) KR102673448B1 (es)
CN (1) CN110462022A (es)
AU (1) AU2018241852B2 (es)
BR (1) BR112019018344A2 (es)
CA (1) CA3052383A1 (es)
CL (1) CL2019002741A1 (es)
CO (1) CO2019011376A2 (es)
IL (1) IL269546B (es)
MX (1) MX2019011539A (es)
MY (1) MY193485A (es)
PH (1) PH12019502239A1 (es)
RU (1) RU2767340C2 (es)
SG (1) SG11201906920XA (es)
WO (1) WO2018178072A1 (es)
ZA (1) ZA201905024B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111423991B (zh) * 2019-11-18 2022-10-28 宁波大学 一种乳酸菌、筛选及应用
CN112143747B (zh) * 2020-09-09 2022-09-13 昆明理工大学 一种噬菌体裂解酶及其基因、基因重组表达载体与应用
CN115197886B (zh) * 2022-09-14 2022-12-06 江苏朴厚环境工程有限公司 铜绿假单胞菌及其菌剂和在有机氮废水生物强化降解中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3361643A (en) 1964-04-15 1968-01-02 Kikkoman Shoyu Co Ltd Method for cultivating micro-organisms having exoenzyme-producing ability
JPH09163976A (ja) 1995-12-15 1997-06-24 Mitsubishi Heavy Ind Ltd エタノールアミン分解菌及びエタノールアミン含有水の処理方法
NZ570635A (en) 2003-09-12 2010-04-30 New Image Internat Ltd Bio-active delivery system using lipids extracted from milk to coat the active substance
JP2005163976A (ja) * 2003-12-04 2005-06-23 Tokai Rubber Ind Ltd 筒形防振マウント
JP2005304362A (ja) 2004-04-20 2005-11-04 Nippon Shokubai Co Ltd １，３−プロパンジオール及び／又は３−ヒドロキシプロピオン酸を製造する方法
HUP0700552A2 (en) 2007-08-27 2009-03-30 Janos Dr Feher Method and composition inhibiting inflammation
SG186646A1 (en) 2007-12-13 2013-01-30 Glycos Biotechnologies Inc Microbial conversion of oils and fatty acids to high-value chemicals
JP2009242275A (ja) * 2008-03-31 2009-10-22 Kagaku Shiryo Kenkyusho:Kk 生菌剤
DK2424972T3 (da) * 2009-04-30 2013-10-14 Actogenix Nv Kryobeskyttende midler til frysetørring af mælkesyrebakterier
BR112012013766A2 (pt) 2009-12-08 2015-09-15 Nestec Sa "fórmula infantil com probióticos e componentes de membrana do glóbulo de gordura do leite"
RU2427624C1 (ru) * 2010-05-24 2011-08-27 Российская Федерация, от имени которой выступает Министерство образования и науки Российской Федерации (Минобрнауки России) Способ замораживания молочно-кислых бактерий
JP5784327B2 (ja) * 2011-02-28 2015-09-24 森永乳業株式会社 抗菌剤
CA2836241A1 (en) 2011-06-08 2012-12-13 Nestec S.A. Nutritional compositions having exogenous milk fat globule membrane components
WO2015168534A1 (en) * 2014-05-02 2015-11-05 Novogy, Inc. Therapeutic treatment of gastrointestinal microbial imbalances through competitive microbe displacement
HUP1500332A2 (en) 2015-07-16 2017-01-30 Feher Janos Dr Compositions for maintaining and restoring microbiota-host symbiosis
WO2018083336A1 (en) 2016-11-07 2018-05-11 Biogaia Ab Activated lactobacillus reuteri strains for selective pathogen inhibition in a human microbial community

Also Published As

Publication number Publication date
PH12019502239A1 (en) 2020-06-29
BR112019018344A2 (pt) 2020-03-31
IL269546A (en) 2019-11-28
US20200038461A1 (en) 2020-02-06
WO2018178072A1 (en) 2018-10-04
KR20190132641A (ko) 2019-11-28
RU2767340C2 (ru) 2022-03-17
US20220168365A1 (en) 2022-06-02
RU2019134200A3 (es) 2021-08-13
IL269546B (en) 2022-07-01
KR102673448B1 (ko) 2024-06-07
US11730780B2 (en) 2023-08-22
AU2018241852A1 (en) 2019-10-10
EP3601620A1 (en) 2020-02-05
CA3052383A1 (en) 2018-10-04
RU2019134200A (ru) 2021-04-28
AU2018241852B2 (en) 2024-04-18
CO2019011376A2 (es) 2020-02-07
US11285181B2 (en) 2022-03-29
JP7097382B2 (ja) 2022-07-07
MY193485A (en) 2022-10-17
CN110462022A (zh) 2019-11-15
SG11201906920XA (en) 2019-08-27
US20230338441A1 (en) 2023-10-26
ZA201905024B (en) 2020-12-23
JP2020511971A (ja) 2020-04-23
MX2019011539A (es) 2019-12-11

Similar Documents

Publication Publication Date Title
CO2019008783A2 (es) Compuestos dinucleotidos ciclicos para el tratamiento del cancer
CL2019002741A1 (es) Bacterias de ácido láctico, métodos y usos de las mismos.
CO2020007142A2 (es) Composiciones y métodos para el tratamiento de los trastornos inmunitarios utilizando cepas de bacterias inmunomoduladoras de lactococcus
CL2017002176A1 (es) Identificación bacteriana y prueba de susceptibilidad antimicrobiana.
CO2017013443A2 (es) Composiciones que comprenden cepas bacterianas del género blautia
DOP2016000144A (es) Moduladores de tetrahidropiridopirazinas de gpr6
ECSP15045801A (es) Inhibidores de la phd de 6–(5–hidroxi–1h–pirazol–1–il)nicotinamida
CU24603B1 (es) Imidazopirimidinas diazabicíclicas sustituidas útiles en el tratamiento de trastornos respiratorios
GT201600183A (es) Compuestos orgánicos de monobactam para el tratamiento de infecciones bacterianas
UY37069A (es) Métodos para mejorar la producción de leche mediante la administración de consorcios microbianos
ECSP14017269A (es) Compuestos para tratar la atrofia muscular espinal
CO2017005870A2 (es) Compuestos de isoxazol de ácido hidroxámico como inhibidores de lpxc
CL2019002135A1 (es) Células microbianas, métodos para producir las mismas, y usos de las mismas.
BR112016023707A2 (pt) método para produzir l-aminoácidos com o uso de uma bactéria alcalifílica
UY34201A (es) Compuestos de azaindol y métodos para el tratamiento de vih.
UY37378A (es) Compuestos tricíclicos fusionados de piridazinona útiles para tratar infecciones de orthomyxovirus
CU24408B1 (es) Compuestos de dihidroisoquinolinona sustituida
CU24608B1 (es) Compuestos de dihidrooxadiazinonas sustituidas útiles en el tratamiento de enfermedades hiperproliferativas y métodos para preparar dichos compuestos
CL2018000111A1 (es) Microorganismos para la producción de putrescina u ornitina y procedimiento para la producción de putrescina u ornitina usando los mismos
CU20200041A7 (es) Amidas de imidazopiridina sustituidas
DOP2014000046A (es) COMPOSICIONES Y MÉTODOS PARA TRATAR EL CÁNCER USANDO EL INHIBIDOR DE PI3Kbeta Y EL INHIBIDOR DE LA VÍA DE MAPK, INCLUIDOS LOS INHIBIDORES DE MEK Y RAF
DOP2016000211A (es) Pirazinas moduladoras de gpr6
CL2022003703A1 (es) Compuestos antibióticos, métodos de fabricación de los mismos, composiciones farmacéuticas conteniendo los mismos y usos
CL2016000672A1 (es) Bacteria aislada del género streptomyces
ECSP19016602A (es) Inhibidores de beta-lactamasa